[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$f4upO-RZ8ywbJXuz3-xSm22-M0hPYFcJTs3cSJW-MhaM":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":157},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":55,"related":57},"new-york-city-medium-agar-introduction-principle-composition-uses","New York City (NYC) Medium: Composition, Principle, Uses, and Colony Characteristics","New York City (NYC) medium is a selective medium for Neisseria gonorrhoeae that uniquely supports genital Mycoplasma and Ureaplasma alongside Neisseria. Learn its principle, horse plasma role, colony characteristics, and how it differs from Modified Thayer-Martin agar.",null,"Acharya Tankeshwar","2014-01-26","2026-07-04",false,"culture-media","A 26-year-old woman presents with vaginal discharge and lower abdominal pain. Her clinician suspects pelvic inflammatory disease (PID) — a condition that can be caused by *Neisseria gonorrhoeae*, *Mycoplasma hominis*, or *Ureaplasma urealyticum*, either alone or in combination. An endocervical swab is sent to the laboratory with a request for culture for gonococci and genital mycoplasmas.\n\nModified Thayer-Martin agar — the most widely used gonococcal culture medium — cannot support *Mycoplasma* or *Ureaplasma* growth. Culturing these organisms requires a completely different medium. New York City medium was designed precisely for this scenario: a single selective plate that simultaneously recovers *N. gonorrhoeae*, *M. hominis*, and *U. urealyticum* from the same genital specimen, allowing the laboratory to address all three pathogens in one culture setup.\n\nNew York City agar base was developed initially by Fauer, Weisburd, and Wilson at the New York City Department of Health for selective isolation of pathogenic *Neisseria* species from clinical specimens.\n\nNew York City (NYC) medium is primarily designed to isolate pathogenic *Neisseria*. It also supports the growth of genital mycoplasmas (*Mycoplasma hominis* and *Ureaplasma urealyticum*). New York City (NYC) medium is helpful in the diagnosis of gonorrhea and recognition of active or asymptomatic mycoplasma infections. It is a transparent medium.\n\n![Neisseria gonorrhoeae in New York City Medium - Neisseria gonorrhoeae in New York City Medium(Imagesource)](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FNeisseria_gonorrhoeae_in_New_York_City_Medium.jpg)Figure: *Neisseria gonorrhoeae* in New York City Medium (Imagesource)\n\n## Principle\n\nNYC medium is both selective (suppressing normal flora while allowing *Neisseria* and genital mycoplasmas to grow) and transparent (enabling observation of the distinctive small colony types produced by these organisms).\n\n**Why NYC medium supports Mycoplasma and Ureaplasma when MTM does not:**\n\n*Mycoplasma hominis* and *Ureaplasma urealyticum* are the smallest self-replicating bacteria and lack a cell wall entirely. They have two distinctive growth requirements that standard Neisseria media cannot meet:\n\n1. **Cholesterol and lipids** — Mycoplasmas incorporate exogenous cholesterol into their cell membranes (they cannot synthesise their own). Horse plasma in NYC medium is a rich source of cholesterol and phospholipids that Mycoplasmas require. GC agar base in MTM contains no plasma.\n2. **Enriched peptide and nucleotide environment** — Mycoplasmas have highly reduced genomes with limited biosynthetic capacity, making them dependent on preformed nucleotides and amino acids in the medium. The combination of horse plasma, horse hemoglobin, and yeast autolysate in NYC medium provides this enriched nutritional environment.\n\n**Component roles:**\n\n| Component | Function |\n| --- | --- |\n| Proteose peptone | Nitrogen, amino acids for Neisseria growth |\n| Corn starch | Neutralises toxic fatty acids that inhibit *N. gonorrhoeae* |\n| Glucose (dextrose) | Carbon and energy source |\n| Dipotassium + monopotassium phosphate | pH buffering |\n| **Horse hemoglobin (sedimented horse RBCs)** | Provides hemin (X factor) for *Neisseria*; lysis releases haem into medium |\n| **Citrated horse plasma** | Provides cholesterol, lipids, and growth factors for Mycoplasma\u002FUreaplasma; also enriches for *Neisseria* |\n| **Yeast autolysate** | Provides CO2 (via oxaloacetic acid pathway); reduces *Neisseria* lag phase; enhances colony size and number |\n| Vancomycin | Inhibits Gram-positive bacteria |\n| Colistin | Inhibits Gram-negative bacilli including *Pseudomonas*; acts synergistically with trimethoprim |\n| Trimethoprim | Inhibits *Proteus* swarming; synergistic with colistin against Gram-negative bacilli |\n| Amphotericin B (or nystatin) | Inhibits yeasts and fungi |\n\n**The yeast autolysate CO2 mechanism — a distinctive feature of NYC medium:** *N. gonorrhoeae* is capnophilic — it requires elevated CO2 (5–10%) for optimal growth. Yeast autolysate contains oxaloacetic acid, which gonococci metabolise intracellularly to produce CO2. This means NYC medium partially self-supplies the CO2 requirement, reducing (though not eliminating) the dependence on a CO2 incubator or candle jar compared to MTM. This is particularly advantageous in resource-limited settings where CO2 supply is inconsistent.\n\n**Transparent medium — why it matters:** Unlike the opaque red-brown appearance of MTM or chocolate agar, NYC medium is transparent to translucent. This transparency allows direct microscopic examination of colonial morphology on the plate and makes it easier to identify the tiny \"fried-egg\" colonies of genital mycoplasmas alongside larger gonococcal colonies.\n\n## Uses of New York City Medium\n\n**1. Primary isolation of *Neisseria gonorrhoeae* from urogenital specimens** NYC medium is used for the same clinical indications as MTM: urethral swabs, endocervical swabs, vaginal swabs, rectal swabs, and pharyngeal swabs from patients with suspected gonorrhoea.\n\n**2. Simultaneous isolation of genital mycoplasmas alongside Neisseria** The unique advantage of NYC medium is its ability to support *Mycoplasma hominis* and *Ureaplasma urealyticum* growth from the same plate. This is clinically relevant in:\n\n- Pelvic inflammatory disease (PID) — where both *N. gonorrhoeae* and *M. hominis* are implicated\n- Non-gonococcal urethritis (NGU) — where *U. urealyticum* is a recognised cause\n- Postpartum fever and neonatal infections — where *M. hominis* transmission from mother to neonate occurs\n- Infertility investigations — where genital mycoplasma colonisation is under study\n\n**3. *Neisseria meningitidis* isolation from nasopharyngeal specimens** NYC medium supports meningococcal carrier screening from nasopharyngeal swabs, where a mixed upper respiratory flora requires selective suppression.\n\n**4. STI clinic settings requiring multi-pathogen coverage** In sexual health clinics processing high volumes of genital specimens, NYC medium offers the advantage of detecting both gonococcal and mycoplasmal infections from a single plate, potentially reducing the number of media required per specimen.\n\n> **Practical note — NYC medium availability:** NYC medium requires horse plasma and horse hemoglobin, making in-house preparation more complex than MTM (which uses sheep blood). In settings where these components are unavailable, MTM remains the standard. Commercially prepared NYC medium plates are available from major manufacturers but at higher cost than MTM.\n\n## Composition of New York City medium agar base\n\n*Final pH ( at 25°C) 7.4±0.2*\n\n| Ingredients | Gms \u002F Litre |\n| --- | --- |\n| Proteose peptone | 15.0 |\n| Corn starch | 1.0 |\n| Glucose | 5.0 |\n| Sodium chloride | 5.0 |\n| Dipotassium hydrogen phosphate | 4.0 |\n| Potassium dihydrogen phosphate | 1.0 |\n| Agar | 20.0 |\n\n## Procedure for the preparation of New York City medium\n\n1. Suspend 25.50 grams in 320 ml distilled water.\n2. Heat to boiling to dissolve the medium completely.\n3. [Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes](\u002Fautoclave-principle-procedure-types-and-uses\u002F). Avoid overheating.\n4. Cool to 45-50°C and add aseptically 100 ml of sedimented horse blood cells and 60 ml of citrated horse plasma along with rehydrated contents of 1 vial of NYC Supplement and 1 vial of yeast autolysate supplement.\n5. Mix well and pour into sterile Petri plates.\n\n## Colony Characteristics on NYC Medium\n\n[***Neisseria gonorrhoeae***](https:\u002F\u002Fmicrobeonline.com\u002Fneisseria-gonorrhoeae-properties-disease-pathogenesis-and-laboratory-diagnosis\u002F)**:** Colonies appear at 24–48 hours. They are small (0.5–1 mm), grey-white to colourless, raised, convex, smooth, and glistening — identical in appearance to colonies on MTM. The transparent medium background makes these colonies easier to visualise than on the opaque background of MTM. Colony types T1 and T2 (piliated, virulent) predominate in fresh clinical isolates; T3 and T4 (non-piliated) emerge on subculture. All colony types are **oxidase-positive** — [confirmed by tetramethyl-p-phenylenediamine reagent turning colonies dark purple within 10 second](https:\u002F\u002Fmicrobeonline.com\u002Foxidase-test-principle-procedure-and-oxidase-positive-organisms\u002F)s.\n\n[***Neisseria meningitidis***](https:\u002F\u002Fmicrobeonline.com\u002Fneisseria-meningitidis-properties-pathogenesis-and-laboratory-diagnosis\u002F)**:** Larger (1–2 mm), grey to bluish-grey, mucoid colonies due to polysaccharide capsule. Slightly larger and more mucoid than gonococci. Oxidase-positive. Maltose-positive (unlike gonococci — the key biochemical differentiator).\n\n**Genital mycoplasmas on NYC medium:** Mycoplasma and Ureaplasma colonies are very small and require careful examination — often magnification with a stereomicroscope or hand lens:\n\n| Organism | Colony appearance | Size | Special features |\n| --- | --- | --- | --- |\n| *Mycoplasma hominis* | \"Fried-egg\" — dense opaque centre (granular) with flat translucent periphery | 200–300 µm (barely visible to naked eye) | Classic fried-egg morphology; requires 3–5 days |\n| *Ureaplasma urealyticum* | Dark brown \"sea-urchin\" or granular colonies; smaller than *M. hominis* | 15–60 µm (requires magnification) | Urease-positive — brown colour in urea-containing media; requires 2–3 days |\n\n> **Identifying mycoplasma colonies on NYC medium:** Because mycoplasma colonies are so small relative to gonococcal colonies, they can be missed during routine plate reading. After 48–72 hours, hold the NYC plate up to oblique light and scan the plate surface systematically with magnification. The fried-egg morphology of *M. hominis* is distinctive once recognised — the flat, transparent periphery growing out from the opaque centre is unlike any standard bacterial colony.\n\n## Choosing Between NYC, MTM, and Martin-Lewis for Neisseria Isolation\n\n| Feature | NYC Medium | [Modified Thayer-Martin (MTM)](https:\u002F\u002Fmicrobeonline.com\u002Fthayer-martin-agar-composition-preparation-uses-colony-characteristics\u002F) | [Martin-Lewis Agar](https:\u002F\u002Fmicrobeonline.com\u002Fmartin-lewis-agar-principle-composition-and-uses\u002F) |\n| --- | --- | --- | --- |\n| Base | Peptone-corn starch + horse plasma + horse hemoglobin | GC agar + haemoglobin | GC agar + haemoglobin |\n| Enrichment | Horse plasma + yeast autolysate | IsoVitaleX supplement | IsoVitaleX supplement |\n| Antifungal | Amphotericin B | Nystatin | **Anisomycin** |\n| *Mycoplasma hominis* growth | **Yes** | No | No |\n| *Ureaplasma urealyticum* growth | **Yes** | No | No |\n| Medium appearance | **Transparent** | Opaque (chocolate-brown) | Opaque (chocolate-brown) |\n| CO2 self-supply (yeast autolysate) | **Partial** | No | No |\n| Vancomycin-sensitive gonococci | May miss | May miss | May miss |\n| Availability | Moderate — needs horse plasma\u002Fhemoglobin | Wide | Moderate |\n| Best for | STI clinics needing Neisseria + Mycoplasma coverage | Standard gonorrhoea culture | When nystatin batch variability is a concern |\n\n**Decision rule:**\n\n- Need both *Neisseria* and genital Mycoplasma\u002FUreaplasma covered: **NYC medium**\n- Standard gonorrhoea workup, no Mycoplasma concern: **MTM**\n- MTM nystatin batches showing variability in selectivity: **Martin-Lewis** (anisomycin is more stable)\n- Sterile site specimens (joint fluid, blood) or culture-negative cases: **Add non-selective [chocolate agar](https:\u002F\u002Fmicrobeonline.com\u002Fchocolate-agar-composition-uses-colony-characteristics\u002F) alongside any selective medium** — vancomycin-sensitive gonococci will be recovered.\n\n## How to Remember\n\n**NYC medium's defining advantage over MTM is horse plasma + yeast autolysate = Mycoplasma support + CO2 supply.**\n\nTwo ingredients do the work that distinguishes NYC from all other Neisseria media:\n\n1. **Horse plasma** → cholesterol for Mycoplasma membrane → enables *M. hominis* and *U. urealyticum* growth\n2. **Yeast autolysate** → oxaloacetic acid → gonococci metabolise it to CO2 → partial self-supply of the capnophilic requirement → reduces CO2 incubator dependence + reduces lag phase\n\n**The transparent medium as a mnemonic:** NYC medium is transparent; MTM and Martin-Lewis are opaque. The transparency was deliberate — tiny mycoplasma colonies that would disappear against a dark background become visible against a transparent background. If a medium is clear or translucent and used for *Neisseria*, think NYC.\n\n**The four-antibiotic parallel with MTM:** Both NYC and MTM use vancomycin + colistin + trimethoprim for selectivity. The antifungal is the differentiator:\n\n- NYC: **A**mphotericin B (A for **A**merica's NYC)\n- MTM: **N**ystatin\n- Martin-Lewis: **A**nisomycin\n\n**Clinical scenario anchor:** Any time a patient has symptoms that could involve both *N. gonorrhoeae* AND genital Mycoplasma (PID, NGU, postpartum fever), NYC medium is the logical choice because it covers both pathogens on a single plate. MTM would miss the Mycoplasma entirely.\n\n## Limitation and recommendation\n\n1. Some strains of *N. gonorrhoeae* are inhibited by the concentration of vancomycin in the selective media, so the addition of nonselective chocolate agar is recommended, especially in suspect cases that are culture negative or for sterile specimens (e.g., joint fluid)\n\n**References**\n\n1. Faur, Y. C., Weisburd, M. H., Wilson, M. E., & May, P. S. (1974). A new medium for the isolation of pathogenic *Neisseria* from clinical material. *Applied Microbiology*, 27(6), 1041–1045. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1128\u002Fam.27.6.1041-1045.1974>\n2. Tille, P. M. (2017). *Bailey and Scott's Diagnostic Microbiology* (14th ed.). Elsevier.\n3. Greenwood, J. R., Voss, J., Smith, R. F., Wallace, H., Peter, C., Nachtigall, M., Maier, T., Wilber, J., & Butsumyo, A. (1986). Comparative evaluation of New York City and modified Thayer-Martin media for isolation of *Neisseria gonorrhoeae*. *Journal of Clinical Microbiology*, 24(6), 1111–1112.\n4. World Health Organization. (2016). *WHO Guidelines for the Treatment of Neisseria gonorrhoeae.* Geneva: WHO.",[46,49,52],{"question":47,"answer":48},"Why does NYC medium support Mycoplasma and Ureaplasma growth when Modified Thayer-Martin agar does not?","Mycoplasma hominis and Ureaplasma urealyticum are cell wall-deficient organisms with highly reduced genomes that cannot synthesise cholesterol — an essential component of their cell membranes. They must obtain cholesterol from an exogenous source in the culture medium. NYC medium contains horse plasma, which is a rich source of cholesterol and phospholipids that these organisms require for membrane assembly and growth. Modified Thayer-Martin agar uses a haemoglobin supplement and IsoVitaleX growth supplement but contains no plasma, providing no cholesterol source. Additionally, yeast autolysate in NYC medium provides nucleotides and amino acids that support Mycoplasma's limited biosynthetic capacity. The absence of these two components (horse plasma and yeast autolysate) in MTM is why it cannot support Mycoplasma or Ureaplasma growth regardless of the antibiotic composition.",{"question":50,"answer":51},"What is the role of yeast autolysate in NYC medium, and how does it reduce the CO2 requirement?","Yeast autolysate serves two functions in NYC medium. First, it provides a broad range of growth-promoting compounds — vitamins, nucleotides, amino acids, and cofactors — that reduce N. gonorrhoeae's lag phase (the delay before active growth begins), resulting in larger and more numerous colonies compared to media without yeast autolysate. Second, and more distinctively, yeast autolysate contains oxaloacetic acid. N. gonorrhoeae can metabolise oxaloacetate via decarboxylation, producing CO2 as a metabolic byproduct. This endogenous CO2 production partially satisfies the capnophilic requirement of gonococci, reducing (though not eliminating) their dependence on an external CO2 supply. In MTM, no such CO2 self-supply mechanism exists. The practical benefit is that NYC medium produces slightly better colony development in conditions where CO2 supply is inconsistent — relevant in resource-limited settings where CO2 incubators may be unavailable or unreliable.",{"question":53,"answer":54},"How are Mycoplasma hominis and Ureaplasma colonies identified on NYC medium?","Both organisms produce colonies far too small to be seen with the naked eye under normal plate reading conditions. M. hominis produces 'fried-egg' colonies: a dense, granular opaque centre with a flat, transparent peripheral zone spreading around it, typically 200–300 µm in diameter. These require a stereomicroscope or at minimum a hand lens to visualise. U. urealyticum produces even smaller colonies (15–60 µm) that appear dark brown to dark blue-grey and granular under magnification — often described as 'sea-urchin' morphology. To find these colonies on NYC medium after 2–5 days incubation, hold the plate under oblique lighting and scan the area between the visible N. gonorrhoeae colonies systematically under magnification. A useful rapid presumptive test is the urease test: U. urealyticum is strongly urease-positive — applying urease reagent to suspect colonies produces a colour change confirming ureaplasma activity.",[56],"gram-negative-cocci",[58,67,94,110,119,126,133,151],{"slug":59,"title":60,"description":61,"seoTitle":38,"seoDescription":38,"author":62,"createdDate":63,"lastUpdatedDate":41,"draft":42,"category":64,"image":38,"faq":65,"tags":66},"neisseria-meningitidis-properties-pathogenesis-and-laboratory-diagnosis"," Neisseria meningitidis: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria meningitidis causes life-threatening bacterial meningitis and meningococcaemia. Learn its serogroups (A, B, C, W, X, Y), virulence factors (capsule, LOS, fimbriae, IgA protease), clinical features including petechial rash, lab diagnosis (CSF Gram stain, culture, PCR), and vaccines.","Nisha Rijal","2020-07-12","bacteriology",[],[56],{"slug":68,"title":69,"description":70,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":71,"lastUpdatedDate":72,"draft":42,"category":73,"image":38,"faq":74,"tags":93},"rapid-carbohydrate-utilization-test-rcut","RCUT for Neisseria: The Maltose Result That Separates Gonorrhoeae from Meningitidis","Neisseria gonorrhoeae and N. meningitidis look identical under the microscope, but one uses glucose only and the other uses glucose and maltose. RCUT reads that sugar panel in 4 hours, without the false negatives that plagued the old CTA method. Here is the maltose rule, why the test must stay out of a CO2 incubator, and the traps that cause misidentification.","2019-12-11","2026-07-12","biochemical-tests",[75,78,81,84,87,90],{"question":76,"answer":77},"Why is maltose the key sugar in identifying Neisseria?","Because maltose separates the two pathogenic Neisseria that look identical under the microscope. Neisseria gonorrhoeae uses glucose only, while Neisseria meningitidis uses both glucose and maltose. Since glucose is positive for both, it tells you nothing on its own; the maltose result is the discriminator. A memory aid: the M in meningitidis matches the M in maltose. This single result changes the diagnosis from a sexually transmitted infection to a cause of meningitis, along with the treatment and public-health response.",{"question":79,"answer":80},"Why must RCUT not be incubated in a CO2 incubator?","Because dissolved carbon dioxide forms carbonic acid, which turns the phenol red indicator yellow even when the organism has not used any carbohydrate. This produces a false-positive acid reaction in every tube. Although Neisseria are grown in a CO2 atmosphere for primary isolation, the RCUT tubes are incubated in a plain aerobic incubator or water bath at 35 degrees. Grow the organism in CO2, but test it out of CO2.",{"question":82,"answer":83},"Why did RCUT replace the older CTA sugar test?","Because CTA was slow and prone to false negatives. Neisseria produce acid oxidatively rather than fermentatively, so they make very little acid, and the peptone in CTA generates alkaline ammonia that can neutralize that small amount of acid, hiding a true positive. CTA also took 24 to 72 hours. RCUT uses a peptone-free, buffered saline so the weak acid registers, and it gives results in about 4 hours.",{"question":85,"answer":86},"What does it mean if all RCUT sugars stay red?","An organism that produces no acid from any sugar is asaccharolytic. Among the oxidase-positive Gram-negative diplococci, Moraxella catarrhalis is the classic asaccharolytic organism, staying red across glucose, maltose, lactose, and sucrose. It is confirmed with additional tests such as DNase and butyrate esterase. Note that some Neisseria, like N. cinerea, can also appear negative because they over-oxidize the acid to carbon dioxide before it accumulates.",{"question":88,"answer":89},"How is Neisseria lactamica distinguished from Neisseria meningitidis?","By lactose. Both use glucose and maltose, but only Neisseria lactamica also uses lactose, giving a positive lactose result (or a positive ONPG test). N. lactamica is a non-pathogenic commensal of the throat that can otherwise be mistaken for meningococcus, so the lactose or ONPG result is an important safeguard against misidentification.",{"question":91,"answer":92},"Why can contaminated maltose cause a Neisseria misidentification?","Because maltose from some suppliers is contaminated with free glucose. Since Neisseria gonorrhoeae uses glucose, glucose-contaminated maltose can make a gonorrhoeae isolate appear maltose-positive, which would mimic Neisseria meningitidis. Because maltose is the critical result separating those two organisms, this contamination directly causes a wrong identification. Using reagent-grade maltose prevents it.",[56],{"slug":95,"title":96,"description":97,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":98,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":99,"tags":109},"thayer-martin-agar-composition-preparation-uses-colony-characteristics","Thayer-Martin Agar (Modified): Composition, Principle, Uses, and Colony Characteristics of Neisseria","Modified Thayer-Martin (MTM) agar is the standard selective medium for isolating Neisseria gonorrhoeae from genital specimens. Learn its VCNT antibiotic selectivity, GC agar base composition, colony types, and how it compares to NYC medium and Martin-Lewis agar.","2016-06-13",[100,103,106],{"question":101,"answer":102},"Why does Neisseria gonorrhoeae survive colistin in Thayer-Martin agar when most Gram-negative organisms do not?","Colistin (polymyxin E) kills most Gram-negative bacteria by disrupting the outer membrane through binding to lipopolysaccharide (LPS) and displacing calcium and magnesium ions that stabilise the membrane. Neisseria gonorrhoeae has inherent resistance to colistin due to specific modifications in the lipid A component of its LPS — particularly the addition of phosphoethanolamine groups that reduce the net negative charge of the outer membrane surface and decrease colistin binding affinity. These same outer membrane modifications are present in N. meningitidis, explaining why both pathogenic Neisseria species survive in colistin-containing selective media while most other Gram-negative organisms are inhibited.",{"question":104,"answer":105},"What is the significance of T1 and T2 versus T3 and T4 colony types of N. gonorrhoeae, and why does it matter clinically?","N. gonorrhoeae colonies are classified into four types (T1–T4) based on the presence and density of type IV pili on the cell surface. T1 and T2 colonies are small, raised, and glistening — produced by piliated organisms. Pili are major virulence factors that enable the organism to adhere to epithelial cells in the urogenital tract, resist phagocytosis, and initiate infection. T3 and T4 colonies are larger and flatter — produced by non-piliated variants that emerge after repeated subculture in the laboratory. Non-piliated gonococci are avirulent in animal models and cannot efficiently colonise human mucosa. The clinical significance is twofold: (1) fresh clinical isolates should produce T1\u002FT2 colonies, confirming their virulence; and (2) for antibiotic susceptibility testing and research work, only first- or second-passage cultures should be used, because repeated subculture produces T3\u002FT4 non-piliated variants that do not represent the clinical isolate.",{"question":107,"answer":108},"Why must N. gonorrhoeae specimens be inoculated onto Thayer-Martin agar immediately, and what happens if there is a delay?","N. gonorrhoeae has extreme sensitivity to three environmental stresses that make delay fatal: (1) desiccation — the organism dies within minutes on a dry swab due to its lack of protective structures and high membrane permeability; (2) cold temperature — below 35°C, the organism's membrane lipid composition shifts in a way that impairs metabolism and viability; and (3) pH change — metabolic activity of other organisms on the swab produces acid that kills gonococci within hours. In practice, for each hour of delay at room temperature on a plain swab, recovery rates fall significantly. The recommended approach is direct inoculation at the point of collection, with immediate placement into a CO2-enriched environment (CO2 incubator, candle jar, or JEMBEC transport system with CO2-generating tablet). JEMBEC plates — MTM agar in a sealed plastic bag with a CO2-generating sodium bicarbonate tablet — were developed specifically to maintain CO2 levels and temperature during transport, allowing up to 24–48 hour transport with acceptable recovery.",[56],{"slug":111,"title":112,"description":113,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":114,"lastUpdatedDate":115,"draft":42,"category":64,"image":38,"faq":116,"tags":117},"gram-negative-cocci-coccobacilli-medical-significance-list-bacteria-diseases","Gram-Negative Cocci and Coccobacilli of Medical Significance: List, Diseases, and Lab Identification","The medically important Gram-negative cocci include Neisseria gonorrhoeae (gonorrhoea, ophthalmia neonatorum), N. meningitidis (meningitis), and Moraxella catarrhalis (otitis media, COPD). This hub covers all GN cocci and coccobacilli with diseases, key properties, and lab identification links.","2016-04-11","2026-07-18",[],[56,118],"bacterial-classification",{"slug":120,"title":121,"description":122,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":123,"lastUpdatedDate":41,"draft":42,"category":64,"image":38,"faq":124,"tags":125},"differences-neisseria-gonorrhoeae-neisseria-meningitides","Differences between Neisseria gonorrhoeae and Neisseria meningitidis: A Complete Comparison","N. gonorrhoeae and N. meningitidis are both Gram-negative diplococci but differ fundamentally in capsule, diseases, transmission, maltose fermentation, serogroups, vaccine availability, and treatment. This complete comparison table covers all key distinguishing features for lab identification and clinical practice.","2015-11-24",[],[56],{"slug":127,"title":128,"description":129,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":130,"lastUpdatedDate":41,"draft":42,"category":64,"image":38,"faq":131,"tags":132},"neisseria-gonorrhoeae-properties-disease-pathogenesis-and-laboratory-diagnosis","Neisseria gonorrhoeae: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria gonorrhoeae causes gonorrhoea — the second most common STI globally. Learn its Gram-negative diplococcus properties, virulence factors (pili, Opa proteins, IgA protease, LOS, PorB), diseases (urethritis, PID, ophthalmia neonatorum), lab diagnosis (Gram stain, culture, NAAT), and AMR resistance timeline.","2013-06-10",[],[56],{"slug":134,"title":135,"description":136,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":137,"lastUpdatedDate":138,"draft":42,"category":64,"image":38,"faq":139,"tags":149},"fluorescent-treponemal-antibody-absorption-fta-abs-test","FTA-ABS Test: Interpretation, When It Confirms Syphilis, and FTA-ABS vs TPPA","How to interpret an FTA-ABS result: what reactive-plus-reactive-RPR confirms, why FTA-ABS stays positive for life, why it cannot monitor treatment, and how it now compares to TPPA in modern syphilis testing.","2013-06-03","2026-07-20",[140,143,146],{"question":141,"answer":142},"Why does the FTA-ABS test remain positive for life after treated syphilis, and what are the implications?","The FTA-ABS detects IgG antibodies directed specifically against Treponema pallidum antigens. Once the immune system has generated these antibodies in response to a treponemal infection, immunological memory B cells persist indefinitely and continue producing low levels of anti-treponemal IgG even after the infection has been eradicated by antibiotics. Antibiotic treatment kills the bacteria and stops the stimulus for new antibody production, but it cannot eliminate existing long-lived plasma cells or memory B cells that were generated during the infection. As a result, anti-treponemal antibody titers decline slowly but rarely reach undetectable levels — most treated patients remain FTA-ABS reactive for years to decades, and many remain positive for life. The clinical implication is that FTA-ABS cannot be used to confirm cure or active infection in a previously treated patient: a reactive FTA-ABS in someone with a history of treated syphilis five years ago simply confirms past infection. Only non-treponemal tests (RPR, VDRL) with their declining titers post-treatment can monitor treatment response and distinguish active from past infection.",{"question":144,"answer":145},"What is the significance of a beaded or atypical fluorescence pattern on FTA-ABS?","A beaded or atypical fluorescence pattern on FTA-ABS, where discrete fluorescent beads appear along the length of the treponemes rather than the uniform homogeneous fluorescence seen in true positive results, is associated with systemic lupus erythematosus (SLE). In SLE patients, auto-antibodies — particularly anti-DNA and anti-nuclear antibodies — can cross-react with treponeme antigens non-specifically, producing fluorescence that follows the outline of the organism but with an irregular, beaded appearance rather than the smooth, bright green fluorescence of a true positive. This atypical beaded pattern on FTA-ABS in a patient with known SLE or strong clinical features of autoimmune disease should be interpreted as a false positive rather than evidence of syphilis. Confirmation with an alternative treponemal test (TPHA or TPPA) and correlation with clinical findings, risk factors for syphilis, and RPR\u002FVDRL results is essential before making a syphilis diagnosis in this context.",{"question":147,"answer":148},"Why is FTA-ABS considered more sensitive than TPHA in early primary syphilis?","In the first 3–4 weeks after T. pallidum infection, the immune response is still developing and antibody concentrations are low. Both FTA-ABS and TPHA detect treponemal antibodies, but they differ in their detection mechanisms and sensitivity thresholds at this early stage. FTA-ABS uses fluorescence microscopy to directly visualise antibody coating on individual T. pallidum organisms — even small amounts of antibody produce detectable fluorescence on the treponemes. TPHA requires antibodies to agglutinate T. pallidum-sensitised red blood cells — a threshold event that requires somewhat higher antibody concentrations to produce visible agglutination. Because FTA-ABS can detect treponemal antibodies at slightly lower concentrations than TPHA, it becomes positive 1–2 weeks earlier in the primary stage, when antibodies are just beginning to appear. In established primary syphilis with a visible chancre, FTA-ABS has approximately 85–90% sensitivity compared to TPHA's 65–76% — a meaningful difference that makes FTA-ABS the preferred test when primary syphilis is strongly suspected and TPHA is negative.",[56,150],"immunofluorescence",{"slug":152,"title":153,"description":153,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":137,"lastUpdatedDate":154,"draft":42,"category":64,"image":38,"faq":155,"tags":156},"venereal-disease-research-laboratory-vdrl-test","VDRL Test: Principle, Procedure, Results","2026-07-05",[],[56],[158,164,171,176,180,184,189,194,198,202],{"slug":159,"name":39,"description":160,"image":161,"body":162,"postCount":163},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":165,"name":166,"description":167,"image":168,"body":169,"postCount":170},"ashma-shrestha","Ashma Shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":172,"name":173,"description":174,"image":38,"body":38,"postCount":175},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":177,"name":178,"description":174,"image":38,"body":38,"postCount":179},"samikshya-acharya","Samikshya Acharya",20,{"slug":181,"name":182,"description":174,"image":38,"body":38,"postCount":183},"alisha-tripathi","Alisha Tripathi",6,{"slug":185,"name":186,"description":187,"image":38,"body":38,"postCount":188},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":190,"name":191,"description":192,"image":38,"body":38,"postCount":193},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":195,"name":196,"description":174,"image":38,"body":38,"postCount":197},"srijana-khanal","Srijana Khanal",18,{"slug":199,"name":200,"description":192,"image":38,"body":38,"postCount":201},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":203,"name":62,"description":174,"image":38,"body":204,"postCount":205},"nisha-rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]